RADIESSE^®
- Nasolabial folds and HIV lipoatrophy
RADIESSE injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

- Hands
RADIESSE^® injectable implant is indicated for hand augmentation to correct volume loss in the dorsum of the hands.

RADIESSE^® (+)
RADIESSE^® (+) Lidocaine injectable implant is indicated for plastic / reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands.

In 2003, Radiesse^® achieved CE Certification, the European Union standard for product safety. In 2006, Radiesse^® was also approved by the FDA, the American Regulatory Authority. Most recently, Radiesse^® is the first facial filler to receive US-FDA approval for Hand augmentation. Radiesse^® has more than 250 publications and is proven to be safe and effective.

Generally, the volumization and wrinkle-filling effect will be visible immediately after injection. Radiesse^® and Radiesse^® Lidocaine works to lift and define key areas around the lower face for an overall smoother appearance. By stimulating your body’s own natural collagen production, the effects of skin quality improvement by Radiesse^® will continue over time.

The duration of the results depends on age, skin type, lifestyle and metabolism, and of course, the area treated. Radiesse^® results are usually durable and can last up to 12 months in many patients.

Radiesse^® is gently injected into the skin, usually in small amounts, with a fine needle or cannula. Radiesse^® is usually injected under the skin in the middle and lower face, as well as the dorsum of hands. One treatment session typically lasts around 30 minutes, but might take longer if multiple areas are being treated in the same session.

Most adverse reactions are injection-site related and often transient. These include slight redness, swelling, itching, bruising, and pain at injection sites. They are generally mild to moderate in severity and disappear on their own shortly after injection (typically within one or two days).

Less common reactions such as inflammation, infection, fistulisation, hardening, and slight discolouration of the treated areas may also occur. If you suffer from poor wound healing, delayed healing may occur. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures.

Prior to treatment, your Healthcare Practitioner will inform you about the possible risks and side effects.

The filler may be felt for a short time after the treatment until it completely integrates with the skin.